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Summary  
Long-term changes of neurotransmitter release are critical for proper brain function. However, 
the molecular mechanisms underlying these changes are poorly understood. While protein 
synthesis is crucial for the consolidation of postsynaptic plasticity, whether and how protein 
synthesis regulates presynaptic plasticity in the mature mammalian brain remains unclear. Here, 
using paired whole-cell recordings in rodent hippocampal slices, we report that presynaptic 
protein synthesis is required for long-term, but not short-term, plasticity of GABA release from 
type-1 cannabinoid receptor (CB1)-expressing axons. This long-term depression of inhibitory 
transmission (iLTD) involves cap-dependent protein synthesis in presynaptic interneuron axons 
but not somata. Translation is required during the induction, but not maintenance, of iLTD. 
Mechanistically, CB1 activation enhances protein synthesis via the mTOR pathway. 
Furthermore, using super-resolution STORM microscopy, we revealed eukaryotic ribosomes in 
CB1-expressing axon terminals. These findings suggest that presynaptic local protein synthesis 
controls neurotransmitter release during long-term plasticity in the mature mammalian brain. 
 
Highlights 
 Presynaptic protein synthesis is required for long-term depression of GABA release 
 iLTD involves cap-dependent translation in interneuron axons but not somata  
 CB1 activation enhances protein translation via mTOR signaling 
 Eukaryotic ribosomes are present in inhibitory interneuron axons and terminals 
 
eTOC Blurb 
The role of presynaptic translation in long-term plasticity in the mature mammalian brain is 
controversial. Younts et al. find that presynaptic protein synthesis is essential for long-term 
plasticity of GABA release at rodent hippocampal inhibitory synapses. 
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Introduction 
Long-term plasticity of neurotransmitter release critically regulates circuit function (Castillo, 
2012). Despite decades of research, the molecular basis of long-term changes in 
neurotransmitter release remains unsolved. While synthesis of new protein is required for 
stabilizing synapses during postsynaptically-expressed forms of long-term plasticity (e.g. long-
term potentiation; LTP and long-term depression; LTD) (Buffington et al., 2014; Santini et al., 
2014), whether and how presynaptic protein synthesis is involved in long-term presynaptic 
plasticity in the mature mammalian brain is unclear. Resolving this issue is important because 
LTP and LTD are linked to cognition, and dysregulated translation during long-term plasticity is 
associated with autism, Fragile X Syndrome, and Alzheimer Disease (Buffington et al., 2014; 
Darnell and Klann, 2013; Santini et al., 2014).  
 
Presynaptic local protein synthesis, a process whereby mRNAs are translated in axons and 
terminals, can endow remote neuronal compartments with the flexibility to rapidly respond to 
local synaptic activity, independent of the soma (Alvarez et al., 2000). Although ribosomes have 
routinely been documented in mammalian axonal growth cones during early embryonic 
development, as well as in regenerating, cultured, and peripheral sensory axons (for recent 
reviews, see Crispino et al., 2014; Gomes et al., 2014; Holt and Schuman, 2013; Jung et al., 
2014), the prevailing view is that fully developed axons in the healthy mammalian brain are 
incapable of supporting protein synthesis. In non-mammalian preparations, where translation 
inhibitors can be injected into relatively large axons, a role for local protein synthesis during 
long-term plasticity has been established (Beaumont et al., 2001; Martin et al., 1997; Zhang and 
Poo, 2002). Mammalian central nervous system (CNS) axons are considerably smaller and 
therefore, more difficult to experimentally manipulate. To date, a direct demonstration for a 
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requirement for presynaptic protein synthesis during long-term plasticity in an intact mammalian 
CNS circuit is lacking. Moreover, there is very little evidence for the presence of ribosomes 
inside fully developed presynaptic axon terminals.  
 
One of the most ubiquitously expressed forms of presynaptic plasticity in the mature CNS is 
mediated by retrograde endocannabinoid (eCB) signaling (Castillo et al., 2012; Kano et al., 
2009). eCBs are lipids mobilized by postsynaptic activity that travel backward across the 
synapse and bind presynaptic Gi/o-coupled type-1 cannabinoid (CB1) receptors to suppress 
neurotransmitter release. In the hippocampus, CB1 receptors are highly expressed on 
GABAergic inhibitory interneuron axon terminals where they mediate both short-term and long-
term plasticity. Short-term plasticity in the form of depolarization-induced suppression of 
inhibition (DSI) typically lasts less than a minute and is likely due to a transient reduction of 
presynaptic calcium influx (Kano et al., 2009). Long-term depression of inhibition (iLTD) involves 
more sustained CB1 activation (Chevaleyre and Castillo, 2003), downregulation of PKA 
(Chevaleyre et al., 2007), and a long-lasting reduction in GABA release. How eCBs control 
neurotransmitter release during long-term plasticity is incompletely understood. Although striatal 
eCB-LTD was reported to involve translation (Adermark et al., 2009; Yin et al., 2006) but see 
(Jung et al., 2012), the mechanism that triggers protein synthesis remains unknown. 
Furthermore, direct evidence that CB1 activation leads to protein synthesis is unavailable. 
 
To determine the role of presynaptic protein synthesis in iLTD, we performed long-term paired 
electrophysiological recordings on synaptically connected inhibitory interneurons and CA1 
pyramidal cells in acute rodent hippocampal slices, where local microcircuits are intact. Using 
single-cell manipulations to block protein translation, we found that iLTD requires protein 
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synthesis exclusively in presynaptic interneurons, most likely in axons. We also show that CB1 
activation increases protein synthesis in an mTOR-dependent manner, and that iLTD involves 
cap-dependent translation. Moreover, using stochastic optical reconstruction microscopy 
(STORM), we provide evidence that eukaryotic ribosomes are localized inside CB1-expressing 
interneuron axon terminals. Our findings establish that presynaptic protein synthesis controls 
neurotransmitter release during long-term plasticity in the mature mammalian CNS. 
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Results 
Long-term, but not short-term, eCB-mediated plasticity requires protein synthesis 
To assess if eCB-mediated iLTD involves protein synthesis, we first elicited heterosynaptic iLTD 
(Chevaleyre and Castillo, 2003) by theta-burst stimulation (TBS) of presynaptic inputs onto 
whole-cell voltage clamped CA1 pyramidal cells in acute hippocampal slices. Compared with 
interleaved controls, acute bath application of either cycloheximide or anisomycin, two 
mechanistically distinct inhibitors of eukaryotic ribosome peptide elongation, impaired iLTD 
(Figure 1A).  iLTD can also be triggered with postsynaptic activity such as multiple episodes of 
DSI (mDSI) (Younts et al., 2013). Compared with controls, acute bath application, but not 
postsynaptic loading of cycloheximide (Yin et al., 2006) or anisomycin, blocked mDSI-iLTD 
(Figure 1B), suggesting that postsynaptic translation is dispensable for iLTD. Neither 
cycloheximide nor anisomycin affected the magnitude or duration of short-term plasticity 
triggered with DSI (Figure 1C,D), indicating that eCB release and CB1 activation properly 
function when blocking protein synthesis. Using fluorescent non-canonical amino acid tagging 
(FUNCAT), a technique that permits visualization of newly synthesized proteins (Dieterich et al., 
2010), we confirmed that cycloheximide and anisomycin block translation in slices (Figure 
1E,F). Taken together, these results show that protein translation is essential for long-term, but 
not short-term, inhibitory plasticity. 
 
Protein synthesis is required for the induction, but not maintenance, of iLTD 
Bypassing eCB production and directly activating presynaptic CB1 with the selective agonist 
WIN 55,212-2 (WIN) induces chemical-iLTD (Chevaleyre and Castillo, 2003; Chevaleyre et al., 
2007; Heifets et al., 2008). Using extracellular field inhibitory postsynaptic potential (fIPSP) 
recordings from the cell body layer, we found that WIN paired with presynaptic activity triggered 
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iLTD (Heifets et al., 2008), which was expressed presynaptically as reflected by an increased 
paired-pulse ratio (i.e. reduced release probability, Pr) (Figure 2A). Cycloheximide or 
anisomycin abolished iLTD and the associated change in Pr (Figure 2A). To address whether 
translation is necessary for the induction or maintenance of iLTD, we acutely exposed slices to 
cycloheximide during or after CB1 activation and found that protein synthesis was not required 
during the maintenance-phase of iLTD (Figure 2B). Neither cycloheximide nor anisomycin 
affected basal inhibitory synapse strength (Figure 2C), indicating that protein synthesis is 
specifically required for long-term plasticity, and that constitutive protein synthesis does not 
significantly alter GABA release. As expected, iLTD was prevented in slices exposed to the 
selective CB1 inverse agonist/antagonist AM251 or SR 141716 (Figure 2D). We also examined 
the potential contribution of mRNA transcription to iLTD. iLTD remained intact when 
transcription was blocked with actinomycin-D (Figure S1A), and actinomycin-D efficacy was 
confirmed using RT-PCR in slices (Figure S1B). Collectively, these findings indicate that protein 
synthesis, and not transcription, is required for the induction, but not maintenance, of iLTD. 
 
CB1 activation enhances protein translation 
Given that CB1-mediated iLTD requires protein synthesis, we next tested whether CB1 activation 
can promote translation. To increase the likelihood of detecting and quantifying potential CB1-
mediated changes in protein synthesis, we used FUNCAT on cultured primary hippocampal 
neurons. Cultured neurons mainly express CB1 in axons, but unlike inhibitory interneurons in 
situ, they also express CB1 in soma and dendrites (Irving et al., 2000; Twitchell et al., 1997). 
Using MAP2 labeling to identify neurons, we found that WIN increased translation (Figure 
3A,B). Co-application of WIN with AM251 abolished this effect (Figure 3A,B), indicating that 
CB1 activation triggered translation. AM251 treatment alone did not significantly change the 
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FUNCAT signal (Figure 3A,B), suggesting that basal CB1 signaling is not coupled to protein 
synthesis. As expected, the WIN-induced increase in FUNCAT signal was greatly reduced by 
cycloheximide. Using the selective agonist DHPG, we confirmed that group I metabotropic 
glutamate receptors (mGluRs) engage protein synthesis (Huber et al., 2000), indicating the 
FUNCAT assay worked as intended. We also assessed protein translation in CB1-expressing 
axons and found that the FUNCAT signal in the presence of WIN was reduced by AM251 
(Figure 3C). We conclude that neuronal CB1 activation increases newly synthesized protein in 
neurons and axons.  
 
Presynaptic CB1-mediated iLTD requires mTOR signaling and cap-dependent translation 
CB1 can signal via the mammalian target of rapamycin (mTOR), p38 mitogen-activated protein 
kinase (MAPK), and/or MAPK/extracellular signal-regulated kinase (ERK) pathways (Howlett et 
al., 2002). Each of these pathways is known to regulate protein synthesis and play a role in 
postsynaptic forms of LTP and LTD (Buffington et al., 2014; Santini et al., 2014). To test if CB1 
activation increases protein synthesis in an mTOR-dependent manner, we measured translation 
using FUNCAT in primary neurons and found that the mTOR selective inhibitor torin-2 abolished 
the WIN-induced increase in translation (Figure 4A,B). Application of torin-2 alone had no 
significant effect on protein synthesis suggesting that mTOR does not regulate constitutive 
protein synthesis (Figure 4A,B). To examine whether mTOR plays a role in iLTD, we triggered 
iLTD in acute hippocampal slices. Compared with interleaved controls, torin-2 abolished 
synaptically (Figure 4C) and chemically-induced iLTD (Figure 4D). Similar to protein synthesis 
(Figure 2B), mTOR signaling was required during the induction, but not maintenance, of iLTD 
(Figure 4D). Notably, torin-2 alone did not affect basal inhibitory synapse strength (104.5 ± 
2.2% of baseline, n = 4, p = 0.19735, paired t-test, data not shown), suggesting that constitutive 
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mTOR signaling does not modify basal GABA release. In addition, a different mTOR inhibitor, 
rapamycin, impaired iLTD (Figure 4E). We further examined the contribution of cap-dependent 
protein synthesis to iLTD. Chemical-iLTD was blocked in slices exposed to 4EGI-1 (Figure 4E), 
which disrupts the eukaryotic initiation factor 4F (eIF4F) complex at the level of eIF4E and 
eIF4G (Moerke et al., 2007), as well as ISRIB (Figure 4E), which interferes with translation 
initiation by preventing the effects of phosphorylated eIF2α (Sekine et al., 2015). Neither 4EGI-1 
nor ISRIB alone had a significant effect on basal inhibitory fIPSP amplitude (4EGI-1: 106.4 ± 
8.0% of baseline, n = 4; p = 0.48092, paired t-test; ISRIB: 96.2 ± 2.6% of baseline, n = 7, p = 
0.1974, paired t-test, data not shown), further signifying that the effects of blocking translation 
were specific to long-term plasticity. We found a partial block of iLTD in slices treated with the 
p38 MAPK inhibitor SB 202190 whereas the ERK/MAPK inhibitor U-0126 had no effect (Figure 
4E). Collectively, our results demonstrate that CB1 activation drives protein synthesis in an 
mTOR-dependent manner and that cap-dependent translation is essential for iLTD. 
 
Presynaptic, but not postsynaptic, cap-dependent translation is critical for iLTD 
To directly test a role for presynaptic protein synthesis in iLTD at the single-cell level, we 
performed long-term paired electrophysiological recordings (up to 5 hrs) between individual 
hippocampal interneurons and CA1 pyramidal cells. Paired recordings allow independent 
control over presynaptic and postsynaptic signaling, thereby providing a means to study 
neurotransmitter release from fully developed GABAergic synaptic terminals in an intact circuit. 
Protein synthesis was inhibited at the single-cell level using the small molecule, membrane 
impermeable inhibitor, M7GpppG (M7). M7 is an mRNA cap analog that competes with 
endogenous 7-methyl guanosine 5’-capped mRNAs for binding to eIF4E, one of several 
proteins comprising the eIF4F complex that regulates cap-dependent translation (Sonenberg 
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and Hinnebusch, 2009). Excess M7 has been used previously to disrupt translation-dependent 
forms of long-term plasticity (Beaumont et al., 2001; Huber et al., 2000). To test whether iLTD 
requires presynaptic protein synthesis, M7 was loaded via the patch pipette directly into regular-
spiking, DSI-sensitive and therefore CB1-expressing interneurons (Figure 5A). Remarkably, 
loading M7 presynaptically for >1 hr abolished iLTD (Figure 5B,C, Figure S2A). We quantified 
GABA release during the baseline and after inducing iLTD in three ways: neurotransmitter 
release probability (Pr; calculated as the number of synaptic release events, i.e. the inverse 
failure rate); synaptic efficacy (a measure of synaptic strength calculated by averaging all 
synaptic events including responses and failures); and synaptic potency (which is the average 
of only synaptic responses). Pr, synaptic efficacy (Figure 5B,C), and potency (baseline: 34.5 ± 
12.8 pA vs. after iLTD induction: 31.8 ± 11.0 pA, n = 6; p = 0.50625, paired t-test, data not 
shown) remained stable (for up to 3 hrs) after attempting to induce iLTD. These results reinforce 
the idea that disrupting constitutive presynaptic protein synthesis does not alter basal GABA 
release. M7 did not alter physiological parameters of interneurons such as resting membrane 
potential (M7 loaded presynaptically: -62.9 ± 1.9 mV vs. M7 not loaded presynaptically: -62.1 ± 
1.8 mV; p = 0.73584, unpaired t-test, n = 6 each) or input resistance (M7 loaded presynaptically: 
275.4 ± 42.0 MΩ vs. M7 not loaded presynaptically: 231.5 ± 51.5 MΩ; p = 0.52464, unpaired t-
test, n = 6 each). These results establish that presynaptic protein synthesis is critical for iLTD, 
and further support a mechanism involving cap-dependent protein synthesis.  
 
To examine the contribution of postsynaptic translation to presynaptic plasticity, M7 was loaded 
into CA1 pyramidal cells. As predicted, iLTD remained intact (Figure 5D-F, Figure S2A). The 
magnitude of iLTD, reflected in the Pr and synaptic efficacy measurements, was not significantly 
different from our previous experiments in which M7 was not present (Younts et al., 2013). 
Consistent with multivesicular release from these terminals (Biro et al., 2006), synaptic potency 
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also was reduced (baseline: 34.5 ± 11.7 pA vs. after iLTD induction: 16.8 ± 6.0 pA, n = 6, p = 
0.03423, paired t-test, data not shown). These experiments indicate that iLTD does not “wash-
out” of presynaptic or postsynaptic compartments because iLTD was induced in recordings in 
which the baseline exceeded 1 hr. Notably, iLTD was still CB1-dependent when postsynaptic 
translation was blocked with M7 (Figure S2B), signifying that blocking postsynaptic protein 
synthesis does not alter eCB production or CB1 signaling required for inducing iLTD. To validate 
that M7 worked as intended, we assessed the well-characterized, protein synthesis-dependent 
mGluR-LTD at excitatory Schaffer collateral-to-CA1 pyramidal cell synapses (Huber et al., 
2000), and found that mGluR-LTD, triggered chemically with DHPG, was not observed when M7 
was loaded postsynaptically for ~30 min (Figure S2C). These results demonstrate that 
postsynaptic translation is dispensable for iLTD. 
 
Somatic protein synthesis in presynaptic interneurons is dispensable for iLTD 
Given that CB1 is predominantly localized to hippocampal interneuron axons and terminals in 
situ (Dudok et al., 2015; Katona et al., 1999), that iLTD is expressed presynaptically as reduced 
GABA release (Castillo et al., 2012), and that loading M7 into interneurons blocked iLTD 
(Figure 5A-C, Figure S2A), we hypothesized that translation is required locally in axons and/or 
terminals that are remote from the interneuron cell body. Consistent with this hypothesis, we 
found a significant positive correlation between the amount of time M7 was loaded 
presynaptically and the likelihood of blocking iLTD (Figure S3A), suggesting M7 must diffuse 
into remote axonal compartments to exert its blocking effect. For the experiments in which M7 
was omitted from the presynaptic interneuron, the magnitude of iLTD remained stable and no 
correlation was observed (Figure S3A). To determine if M7 can diffuse into remote axons at 
times matching iLTD block, we used two-photon fluorescence microscopy to track the diffusion 
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of two fluorescent molecules, Alexa Fluor-594 and Lucifer yellow, which are similar in size to M7 
(i.e. M7 proxies). We readily detected M7 proxies in putative axons (Figure S3B,C). To test the 
hypothesis that somatic translation in interneurons is dispensable for iLTD, we performed paired 
recordings and loaded the type-1 ribosome inactivating toxin, gelonin, which irreversibly 
interferes with protein elongation, into regular-spiking, DSI-sensitive interneurons. Given its 
relatively large size (~30 kDa), we reasoned that gelonin introduced via the patch pipette would 
be relatively restricted to the soma and proximal neurites and therefore less effective at blocking 
translation in distal axon terminals. We could only detect gelonin (3-30 μM, labeled with Alexa 
Fluor-488) in somata and proximal dendrites but not in putative axons (Figure S3B,C). 
Functionally, gelonin (3 μM) loaded presynaptically for 105.3 ± 4.9 min failed to block iLTD 
(Figure 6A,B). To assess if gelonin blocked somatic translation, we loaded gelonin (3 μM) for 
~30 min into one of two neighboring CA1 interneurons in slices and performed FUNCAT 
(Figure 6C,D). Gelonin substantially reduced somatic translation in these interneurons (Figure 
6C,D). As a functional positive control in interleaved experiments, we found that gelonin (3 μM) 
loaded postsynaptically for ~30 min readily blocked mGluR-LTD at excitatory synapses onto 
CA1 pyramidal cells (Figure 6E). Finally, we examined the possibility that a somatically 
synthesized protein might traffic along microtubules into axonal compartments during iLTD. 
Slices were pre-incubated and continuously perfused with the microtubule depolymerizing agent 
colchicine (for up to 5 hrs) or nocodazole (for up to 8 hrs). These reagents had no effect on iLTD 
(Figure 6F) or intrinsic membrane properties (Figure S4A), despite nocodazole disrupting 
neuronal microtubule integrity in slices as measured with second harmonic generation 
microscopy (Figure S4B,C). These observations suggest that microtubule-based trafficking 
mechanisms do not participate in iLTD. Taken together, these results indicate that somatic 
translation and transport are not required for iLTD, strongly suggesting that iLTD involves 
presynaptic protein synthesis in axons.  
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Anatomical evidence for ribosomes in mature mammalian axon terminals 
If iLTD involves presynaptic protein synthesis, then ribosomes should be present in CB1-
expressing interneuron axons and terminals. To visualize ribosomes specifically within this 
interneuron type, we co-immunostained mouse and rat hippocampal slices using antibodies 
specific for CB1 and ribosomes. We and others have previously validated the CB1 antibody 
(Dudok et al., 2015; Fukudome et al., 2004). The Y10b antibody is also well-characterized and 
validated, recognizing 5.8S non-coding ribosomal RNA in the 60S subunit. Consistent with 
previous reports (Dudok et al., 2015; Katona et al., 1999), confocal imaging revealed a 
characteristically dense network of CB1-expressing basket-like axons and preterminal axon 
segments encircling CB1-immunonegative CA1 pyramidal cell bodies (Figure 7A, Figure S5A). 
As expected, there was high ribosome density expressed in the perinuclear cytoplasm of CA1 
pyramidal cell bodies (Figure 7A, Figure S5A). With the exception of nucleoli (not shown), 
where 5.8S rRNA is made and spliced, the nucleus was nearly devoid of 5.8S rRNA. We 
validated Y10b staining by treating sections with RNAse A and micrococcal nuclease enzymes, 
which degrade RNA and thus the Y10b epitope. Compared with control, sections pretreated with 
nucleases had substantially less Y10b labeling (Figure 7A, Figure S5A,B). 
 
In an effort to detect ribosomes in CB1-expressing axon terminals, we performed 3D STORM 
imaging (Huang et al., 2008). Using a recently developed combined STORM/confocal imaging 
approach that reliably measures CB1 position in the plasma membrane (Barna et al., 2016; 
Dudok et al., 2015), we visualized 5.8S rRNA molecules within CB1-expressing axon terminals 
(Figure 7B) located in the somatic and dendritic fields of CA1 (Figure S5B). Nuclease 
pretreatment largely eliminated 5.8S rRNA immunostaining from these terminals (Figure 7A,D, 
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Figure S5B). In a complementary set of experiments, we immunolabeled ribosomal protein S6 
(rpS6), which is an integral component of the eukaryotic 40S ribosomal subunit and an effector 
of mTOR signaling. rpS6 molecules were also readily visualized with STORM imaging inside 
CB1-expressing axon terminals (Figure 7C, Figure S5C). The densities of 5.8S rRNA (Figure 
7D) and rpS6 protein (Figure 7E) puncta were significantly higher (by ~90%) in axon terminals 
compared to the corresponding background signal measured from CA1 pyramidal cell nuclei. 
Preterminal axon segments exhibited an intermediate labeling density. Quantitative nanoscale 
analysis showed an identical clustering distribution for 5.8S rRNA and rpS6 localization points 
within CB1-expressing axon terminals (Figure 7F), and dual channel STORM revealed co-
clustering of 5.8S rRNA and rpS6 molecules in these boutons (Figure S6A-C). The mean 
number (± standard deviation) of 5.8S rRNA and rpS6 clusters per bouton was 3.34 ± 0.79 and 
2.92 ± 1.16, and the percentage of ribosome-containing boutons was 91 ± 7% and 83 ± 18%, 
respectively. As expected, CB1-expressing axon terminals containing the presynaptic active 
zone protein bassoon also showed ribosomal labeling (Figure S6D-G). Presynaptic 5.8S rRNA 
STORM signal was observed in CB1-expressing axon terminals from rat hippocampal sections, 
and signal specificity was confirmed in nuclease-treated sections (control, n = 57 boutons vs. 
nuclease treatment, n = 56 boutons, 2 animals each, p <0.0001, Mann-Whitney U test, data not 
shown). Interestingly, presynaptic ribosomal labeling was also detected in parvalbumin-positive 
inhibitory interneuron boutons (Figure S7). The number of 5.8S rRNA and rpS6 clusters per 
bouton was 2.41 ± 0.84 and 2.42 ± 1.03, and the percentage of ribosome-containing boutons 
was 82 ± 11% and 77 ± 14%, respectively. Jointly, these data provide strong anatomical support 
for eukaryotic ribosomes in mammalian axon terminals of inhibitory interneurons.  
 
To determine the nanodomain distribution of ribosomes within presynaptic CB1-expressing 
interneuron terminals, we employed dual-channel 3D directSTORM imaging. We previously 
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established that CB1 localization points, which delimit the presynaptic bouton, can be fit with a 
convex hull with nanoscale precision (Dudok et al., 2015), thereby defining the membrane of the 
axon terminal (Figure 7H). Dual-STORM imaging uncovered 5.8S rRNA within CB1-expressing 
axon terminals (Figure 7G,H). Quantitative nanoscale distribution analysis uncovered a high 
density of 5.8S rRNA within the presynaptic terminal just inside the plasma membrane (Figure 
7G, Figure S6D-G). The density of 5.8S rRNA just outside the presynaptic plasma membrane, 
corresponding to the synaptic cleft and interstitial space, was virtually zero (Figure 7G). Taken 
together, these findings provide molecular and anatomical evidence for the presence of 
presynaptic ribosomes inside CB1-expressing interneuron terminals.  
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Discussion 
We established that presynaptic protein synthesis is essential for a presynaptically-expressed 
form of long-term plasticity in the mature mammalian brain. We found that CB1 activation 
generates new proteins, and that iLTD likely requires axonal protein synthesis independent of 
somatic translation, transcription, and microtubule-based trafficking mechanisms. Our combined 
molecular and anatomical approach revealed eukaryotic ribosomes in fully-developed CB1-
expressing interneuron axon terminals. Mechanistically, CB1 activation drives the cap-
dependent translation machinery via the mTOR pathway. Translation plays a specific role in 
long-term plasticity since disrupting translation initiation or peptide elongation did not affect 
basal GABA release or short-term plasticity. We also report that protein synthesis is required for 
the induction, but not maintenance, of iLTD. These findings converge on a novel model whereby 
presynaptically synthesized proteins act as a molecular switch to persistently reduce GABA 
release from inhibitory interneuron terminals.  
 
Neurons must coordinate gene expression at thousands of synapses distant from their soma. 
Local translation can impart axons and dendrites with computational autonomy to rapidly 
respond to the environment, independent of the soma (Alvarez et al., 2000; Holt and Schuman, 
2013; Jung et al., 2014). The concept of local presynaptic protein synthesis was first proposed 
nearly 50 years ago (for a thorough review, see Alvarez et al., 2000). Presynaptic local protein 
synthesis during long-term plasticity has since been demonstrated in non-mammalian 
preparations such as crayfish (Beaumont et al., 2001), sea slug (Martin et al., 1997), frog 
(Zhang and Poo, 2002), and leech (Yuan and Burrell, 2013). An advantage of these 
preparations is that the presynaptic axons are relatively large and can be directly manipulated 
via pressure-injection of translation inhibitors. In contrast, mammalian axons are much smaller 
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and therefore more difficult to access. Previous research in rodents has so far relied on non-
physiological treatments such as axotomy or non-specific manipulations such as blocking 
postsynaptic protein synthesis to infer a role for presynaptic translation during long-term 
plasticity (Barnes et al., 2010; Calixto et al., 2003; Hagena and Manahan-Vaughan, 2013; 
Huang and Hsu, 2004; Huang et al., 1994; Kelly et al., 2000; Yin et al., 2006). Protein synthesis 
can be upregulated in response to injury or occur in neighboring neurons or glia. We used long-
term paired recordings and single-cell manipulations in a locally intact circuit to demonstrate that 
presynaptic, likely axonal, protein synthesis is essential for regulating neurotransmitter release 
during long-term plasticity. Our findings also indicate that presynaptic protein synthesis during 
long term-plasticity is evolutionarily conserved from invertebrates to mammals.  
 
The presence of ribosomes has been well documented in mammalian axonal growth cones, 
regenerating axons, and peripheral sensory axons (Crispino et al., 2014; Jung et al., 2014), 
However, failure to detect ribosomes in mature mammalian CNS axons (Palay and Palade, 
1955), and the observation that neuronal somata can source protein to axons (Droz and 
Leblond, 1963), likely gave rise to the notion that presynaptic compartments in the mature 
mammalian brain do not synthesize proteins. This dogma persisted despite ribosomes being 
identified in axon initial segments of mammalian cortical principal cells (Jones and Powell, 1969; 
Steward and Ribak, 1986) and spinal nerves (Koenig et al., 2000). Ribosome-associated 
proteins, initiation and elongation factors have now been detected in whole-brain presynaptic 
bouton preparations (Wilhelm et al., 2014), and hundreds of mRNA transcripts encoding 
presynaptic proteins were isolated from cultured cortical axons (Taylor et al., 2009), 
hippocampal slices of CA1 neuropil (Cajigas et al., 2012), and retinal ganglion cell axons in vivo 
(Shigeoka et al., 2016). In addition, axonal protein synthesis has recently been linked with 
synaptic transmission and axon maintenance (Shigeoka et al., 2016; Yoon et al., 2012), which 
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may be dysregulated in Alzheimer’s disease (Baleriola et al., 2014) and Fragile X Syndrome 
(Akins et al., 2012; Christie et al., 2009). These studies and ours collectively raise the strong 
possibility that the soma is not the exclusive origin of presynaptic proteins. Further, our work 
establishes that presynaptic ribosomes play a functional role in presynaptic long-term plasticity.  
 
Our findings using various protein synthesis inhibitors suggest that presynaptic CB1-expressing 
interneuron terminals contain eukaryotic ribosomes. We used super-resolution STORM 
microscopy to provide direct evidence for ribosomes in axonal boutons and to quantify, in a cell-
type- and synapse-specific manner, their nanoscale spatial distribution. We found a high density 
of ribosomes within 25-400 nm of the presynaptic plasma membrane, where they are positioned 
to integrate CB1 signaling. It is unclear why previous ultrastructural studies in mature CNS axons 
failed to detect ribosomes in synaptic terminals. Presumably, those studies lacked sufficient 
sensitivity to detect ribosomes or focused exclusively on excitatory synapses. Alternatively, 
ribosomes in certain presynaptic terminals may be disassembled and thus go undetected until 
an external cue (e.g. activity or receptor ligand) initiates translation (Tcherkezian et al., 2010). It 
is also conceivable that certain presynaptic terminals express unconventional ribosomes (Xue 
and Barna, 2012). Regardless of the underlying biological or technical explanation, our study 
demonstrates that eukaryotic ribosomes are present in fully mature CNS inhibitory interneuron 
terminals.  
 
CB1 can transduce signals to several downstream effectors including voltage-gated Ca
2+ and K+ 
channels, PKA, ERK/MAPK, p38-MAPK, and PI3K (Howlett et al., 2002). Many of these 
signaling cascades were originally characterized in heterologous overexpression systems. 
Thus, the precise pathways engaged by CB1 in intact preparations remain unclear. A previous 
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study reported that CB1 activation can indirectly upregulate mTOR signaling, presumably in 
postsynaptic compartments (Puighermanal et al., 2009). Instead, we found that both 
synaptically- and chemically-induced iLTD are coupled to mTOR, suggesting that mTOR 
signaling operates in presynaptic compartments. Using FUNCAT in cultured hippocampal 
neurons, we also directly showed that CB1 activation leads to new protein synthesis in an 
mTOR-dependent manner. To our knowledge, this is the first demonstration that CB1 activation 
causes an overall increase in protein synthesis. Though it is presently not possible to distinguish 
between a requirement for constitutive and/or de novo protein synthesis during forms of 
plasticity in which target protein(s) remain unidentified, mTOR can control eIF4F-mediated cap-
dependent translation initiation, a highly regulated and rate-limiting step (Sonenberg and 
Hinnebusch, 2009). Given our findings that eIF4F is critical for iLTD, these results imply that 
CB1 activation enhances the rate of protein synthesis. Novel methods with improved 
spatiotemporal resolution need to be developed to reveal de novo protein synthesis at 
presynaptic terminals in brain tissue. 
 
Protein synthesis is commonly linked to the maintenance of long-term plasticity (Buffington et 
al., 2014; Santini et al., 2014). We found that blocking translation right after inducing iLTD had 
no effect on long-term plasticity. This observation is consistent with our previous work indicating 
CB1 activation is required during the induction, but not maintenance, of iLTD (Chevaleyre and 
Castillo, 2003). Given that CB1 receptors enhance translation, the newly synthesized protein(s) 
may act as a functional molecular switch to inhibit neurotransmitter release and therefore trigger 
long-term, but not short-term, plasticity. Once the protein(s) are synthesized and iLTD is 
established, protein translation is no longer required to maintain the synapse in a depressed 
state (Klein et al., 2015). While additional research is needed to identify exactly which protein(s) 
are synthesized, candidates include the translation machinery itself, synaptic vesicle-associated 
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signaling proteins, and structural proteins linked with the cytoskeleton, active zone, and 
intercellular adhesion. There is evidence that actin can be locally synthesized in axon growth 
cones, sensory axons, and cultured CNS axons (for reviews, see Gomes et al., 2014; Jung et 
al., 2014), and that CB1 activation leads to cytoskeletal rearrangements including axon growth 
cone collapse/expansion (Argaw et al., 2011; Berghuis et al., 2007; Njoo et al., 2015; Roland et 
al., 2014). Synthesis of a structural/cytoskeletal protein could increase the coupling distance 
between presynaptic calcium channels and the active zone to efficiently suppress GABA 
release. 
 
The impact of iLTD manifests at the circuit level. CB1 receptors expressed on the axon terminals 
of interneurons can persistently gate excitation via somatic and dendritic disinhibition (Basu et 
al., 2013; Younts et al., 2013). In vivo studies suggest that redistribution of inhibitory interneuron 
spiking and spike-timing can reconfigure ensembles of active hippocampal pyramidal cells in 
space and time (Dupret et al., 2013; Klausberger et al., 2005). We propose that presynaptic 
translation in inhibitory interneurons helps orchestrate the excitability of a subset of pyramidal 
cells in specific circuits established during the learning processes. Given the important role of 
protein synthesis in cognitive functions (Buffington et al., 2014; Santini et al., 2014), our results 
also warrant consideration in the context of dysregulated translational control and 
inappropriately balanced excitation and inhibition. Dysregulated translation in inhibitory 
interneurons may be an overlooked mechanism in brain disorders (Buffington et al., 2014; 
Darnell and Klann, 2013).   
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Experimental Procedures 
See Supplemental Experimental Procedures for detailed methods.  
 
Slice preparation and electrophysiology 
Acute transverse hippocampal slices (400 μm thick) were prepared from male and female (P15-
30) Sprague Dawley rats and C57BL/6 mice using standard procedures approved by NIH and 
Albert Einstein College of Medicine Institutional Animal Care and Use Committee guidelines. 
Whole-cell voltage and current clamp recordings were performed with an Axon MultiClamp 
700B amplifier (signals filtered at 2 kHz and digitized at 5 kHz). Stimulation and acquisition were 
controlled with custom software (Igor). Stock reagents were prepared according to the 
manufacturer’s recommendation. All experiments were performed in an interleaved fashion. “n” 
represents number of independent cells or field recordings in slices. 
 
FUNCAT and image analysis  
Acute hippocampal slices (400 µm thick) or primary hippocampal neurons (from E18-19 rats and 
grown in vitro for 18 days) were prepared using standard procedures. Slices were treated with 
reagents as described and then exposed to azidohomoalanine (AHA) for 2.5 hrs before fixation. 
Neuron cultures were pre-incubated with methionine-free medium for 30 min, then incubated 
with AHA for 1.5 hrs and treated with reagents, as described. Following the Click-it® reaction, 
immunocytochemistry was performed. Images were obtained using the same settings for all 
samples within an experiment. Experimenter was blind to the treatment condition. Image 
processing was performed with ImageJ (NIH). 
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STORM microscopy and image analysis  
Experimental procedures were approved by the Hungarian Committee of the Scientific Ethics of 
Animal Research. Acute hippocampal slices (300 µm thick) were prepared from male Sprague-
Dawley rats and C57BL/6N mice (P30-40) according to standard procedures. Tissue 
processing, immunostaining, and imaging was performed as described (Barna et al., 2016; 
Dudok et al., 2015). After data acquisition, the confocal images were deconvolved. Identification 
of single-molecule localization points was performed with NIS-Elements N-STORM module 
(Nikon). Correlated analysis of confocal and STORM images was performed in VividSTORM. 
Localization precision was measured from the standard deviation of coordinates in isolated 
clusters (Dudok et al., 2015) at 13 nm and 34 nm in the lateral and axial dimensions, 
respectively. The localization accuracy for determining the position of one blinking event was 
6.8 nm with single channel STORM and 10.6 nm with dual-channel STORM. Three-dimensional 
STORM renderings of localization points were constructed using Visual Molecular Dynamics 
software. All images within each experiment were processed in parallel using identical imaging 
and analysis conditions. 
 
Statistics 
Summary data are presented as mean ± standard error of mean (SEM), unless otherwise 
indicated. Significance (p <0.05) was assessed with one-way ANOVA (means comparison with 
post hoc Bonferroni test for electrophysiology and FUNCAT, or Tukey test for STORM), 
Student’s paired and unpaired t-tests, Wilcoxon matched-pairs signed rank test, Mann Whitney 
U-test, or Pearson’s correlation coefficient, as indicated.   
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Figure Legends 
Figure 1. Synaptically-induced iLTD involves protein synthesis.  
(A) Whole-cell recordings from CA1 pyramidal cells in acute slices. Presynaptically-induced 
iLTD was blocked by acute bath application of cycloheximide (cyclo, 80 µM) or anisomycin 
(aniso, 20 µM) (washed-out after the induction). Arrow, TBS protocol. For all electrophysiology 
figures, representative traces (1) and (2) correspond to the gray shaded areas (1) and (2) in the 
summary time-course plots. Control: 73.1 ± 2.1% vs. cyclo: 91.4 ± 3.8% vs. aniso: 89.0 ± 5.1%; 
F[2,20] = 11.17646; p = 0.00055, one-way ANOVA. n = number of cells.  
(B) Postsynaptically-induced iLTD was inhibited by acute bath application of cyclo (80 µM) or 
aniso (20 µM) (washed out after the induction). Except for control, cyclo (80 µM) or (20 µM) 
aniso was loaded postsynaptically via the patch pipette for all experiments. Black bar, mDSI 
protocol. Control: 74.3 ± 3.4% vs. cyclo or aniso loaded postsynaptically: 84.8 ± 2.2% vs. cyclo: 
102.5 ± 5.2% vs. aniso: 109.6 ± 5.3%; F[3,28] = 18.99148; p <0.00001, one-way ANOVA. 
Control vs. cyclo or aniso loaded postsynaptically; p = 0.00135, unpaired t-test.  
(C) Short-term eCB-mediated plasticity elicited with DSI was not affected by cyclo (80 µM). 
Arrow, DSI protocol. Control: 63.6 ± 2.4% vs. cyclo: 69.5 ± 3.1%; p = 0.18284, unpaired t-test. 
Slices were exposed to cyclo for no more than 1 hr.  
(D) Similar to panel C but for aniso (20 µM). Control: 68.3 ± 3.0% vs. aniso: 66.4 ± 2.8%; p = 
0.65988, unpaired t-test.  
(E) Cyclo (80 μM) and aniso (20 μM) blocks translation in slices as reflected by reduced 
FUNCAT signal in representative confocal images of the CA1 cell body layer.  
(F) Summary data. FUNCAT fluorescence intensity, in arbitrary units, normalized to control. 
Control: 1.00 ± 0.03 (7 slices) vs. cyclo: 0.44 ± 0.02 (5 slices) vs. aniso: 0.62 ± 0.02 (3 slices); 
F[2,216] = 116.10; ***p < 0.001, one-way  ANOVA;. Regions of interest (ROIs) were randomly 
selected from somata. Numbers in parenthesis refer to number of ROIs analyzed (i.e. 5 
somas/image and ~3 images/slice).  
(A-D): Data are shown as mean ± SEM. 
 
Figure 2. Presynaptic CB1-mediated iLTD requires translation during the induction-phase. 
(A) fIPSP recordings in acute hippocampal slices. Top panel: chemically-induced iLTD (WIN 5 
µM + activity, black bars) was blocked by bath application of cyclo (80 µM) or aniso (20 µM) 
(washed out after the induction). Control: 77.8 ± 2.4% vs. cyclo: 100.6 ± 3.9% vs. aniso: 99.2 ± 
6.6%; F[2,21] = 11.30053; p = 0.00047, one-way ANOVA. SR 141716 (5 µM), a CB1 inverse 
agonist/antagonist was bath applied after WIN to terminate CB1 activation. Picrotoxin (bath 
applied at end of experiment) confirms fIPSPs were GABAA receptor-mediated. Bottom panel: 
translation inhibitors blocked the increased paired-pulse ratio (PPR) associated with iLTD. 
Control: 112.5 ± 3% vs. cyclo: 102.2 ± 1.3% vs. aniso: 101.3 ± 3.4%; F[2,21] = 5.66567; p = 
0.01077, one-way ANOVA. Gray and white bars signify presence of translation inhibitors. Data 
in both panels from same recordings. n = number of slices.  
(B) Protein synthesis was required during the induction, but not maintenance, of iLTD. Slices 
were acutely exposed to cyclo (80 µM) during min -25 to 25 (gray bar) or min 25 to 75 (white 
bar). Control: 74.5 ± 5.2% vs. cyclo min -25 to 25: 98.6 ± 5.2% vs. cyclo min 25 to 75: 82.4 ± 
4.2%; F[2,19] = 5.71536; p = 0.01002, one-way ANOVA.  
(C) Neither cyclo (80 µM) nor aniso (20 µM) had a lasting impact on basal inhibitory synaptic 
transmission: cyclo: 105.1 ± 4.0% compared to baseline, p = 0.2378, paired t-test; aniso: 103.0 
± 4.1% compared to baseline; p = 0.48869, paired t-test. Inhibitors were bath applied for 50 min 
(black bar), as in panels A and B.   
(D) AM251 (5 µM, n = 2) or SR 141716 (5 µM, n = 2) prevented iLTD: 101.2 ± 3.1% compared 
to baseline; p = 0.82567, paired t-test (AM251 and SR 141716 results pooled because there 
was no difference). Slices pre-incubated (>1 hr) and continuously perfused with CB1 blockers. 
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Data are shown as mean ± SEM. 
 
Figure 3. CB1 activation increases protein synthesis in neurons 
(A) Representative fluorescence images of FUNCAT signal acquired from primary hippocampal 
neurons (confirmed with MAP2 immunostaining which exclusively labels neurons) exposed for 
25 min to vehicle control (DMSO), the CB1 agonist WIN (5 µM), WIN and AM251 (both at 5 μM), 
AM251 alone (5 µM), WIN and cyclo (5 µM and 80 µM, respectively), or DHPG (50 µM, 10 min).  
(B) Summary data. FUNCAT fluorescence intensity, in arbitrary units, normalized to control. 
Control (8 wells, 3 replicates): 1.00 ± 0.03 vs. WIN (7 wells, 3 replicates): 1.28 ± 0.04 vs. WIN + 
AM251 (9 wells, 2 replicates): 0.99 ± 0.03 vs. AM251 alone (3 wells, 2 replicates): 0.90 ± 0.04 
vs. WIN + cyclo (4 wells, 2 replicates): 0.63 ± 0.02 vs. DHPG (9 wells, 3 replicates): 1.20 ± 0.04 
(9 wells, 3 replicates); F[5,401] = 28.09; **p <0.01, ****p < 0.0001, one-way ANOVA. ROIs were 
generated from neuronal somata and neurites using MAP2. Numbers in parentheses refer to 
number of images analyzed (i.e. 2-8 neurons/image and ~5 images/well). 
(C) Top panels: representative fluorescence images of FUCAT signal acquired from putative 
axons under CB1-positive puncta exposed to WIN (5 µM) and WIN + AM251 (both at 5 μM). 
Bottom left: wide-field image of a neuron immunostained with CB1 and MAP2. Arrowheads 
indicate putative axons containing CB1 but lacking MAP2 staining. Right: summary data of 
FUNCAT fluorescence intensity, in arbitrary units, normalized to WIN + AM251. WIN (7 wells, 2 
replicates): 1.42 ± 0.09 vs. WIN + AM251 (6 wells, 2 replicates): 1.00 ± 0.02; U = 202, ***p 
<0.001, Mann Whitney. Numbers in parentheses refer to number of images analyzed (i.e. 1-2 
neurons/image and ~5 images/well).  
Data represent mean ± SEM.  
 
Figure 4. CB1-mediated iLTD recruits the mTOR pathway 
(A) Representative fluorescence images of FUNCAT signal acquired from cultured primary 
hippocampal neurons exposed for 25 min to vehicle control (DMSO), WIN (5 µM), WIN (5 µM) 
and the mTOR inhibitor torin-2 (100 nM), and torin-2 alone (100 nM). 
(B) Summary data. FUNCAT fluorescence intensity, in arbitrary units, normalized to control. 
Control (9 wells, 4 replicates): 1.00 ± 0.02 vs. WIN (7 wells, 3 replicates): 1.20 ± 0.04 vs. WIN + 
torin-2 (5 wells, 2 replicates): 1.02 ± 0.06 vs. torin-2 alone (6 wells, 2 replicates): 0.90 ± 0.04. 
F[3,201] = 11.90; ***p<0.001, one-way ANOVA. Numbers in parentheses refer to number of 
images analyzed (i.e. 2-8 neurons/image and ~5 images/well).  
(C) Whole-cell recordings in acute hippocampal slices. Presynaptically-induced TBS-iLTD was 
abolished by torin-2 (100 nM). Control: 70.8 ± 4.3% vs. torin-2: 94.0 ± 3.0%; p = 0.00083, 
unpaired t-test. Slices pre-incubated (>1 hr) and continuously perfused with torin-2. 
(D) fIPSP recordings in acute hippocampal slices. mTOR was required during the induction, but 
not maintenance, of chemical-iLTD. Slices were acutely exposed to torin-2 (100 nM) during min 
-25 to 25 or min 25 to 75. Control: 81.8 ± 3.3% vs. torin-2 min -25 to 25: 95.2 ± 3% vs. torin-2 
min 25 to 75: 72.5 ± 4.6%; F [2,19] = 8.45658; p = 0.00236, one-way ANOVA. 
(E) Summary data for fIPSP recordings showing that mTOR and cap-dependent translation are 
required for chemical-iLTD. Data from panel D were replotted for comparison. iLTD was blocked 
in slices acutely exposed (washed out after induction) to the mTOR inhibitor rapamycin (100 
nM) (control: 74.2 ± 3.4% vs. rapamycin: 91.3 ± 2.3; p = 0.00054) and the cap-dependent 
translation inhibitor 4EGI-1 (1 µM) (control: 80.5 ± 2.6% vs. 4EGI-1: 100.3 ± 3.4%; p = 0.00169). 
ISRIB (1 µM), a different cap translation inhibitor, blocked iLTD in slices pre-incubated (>1 hr) 
and continuously perfused (control: 80.1 ± 2.4% vs. ISRIB: 95.8 ± 4.4%; p = 0.00408). iLTD was 
partially blocked in slices acutely exposed (washed out after induction) to the p38 MAPK 
inhibitor SB 202190 (10 µM) (control: 66.7 ± 3.9 vs. SB 202190: 79 ± 1.2%; p = 0.01661) but not 
the MAPK/ERK inhibitor U-0126 (10 µM) (control: 69.2 ± 5.3% vs. U-0126: 79.8 ± 6.1%; p = 
0.13075). The inactive form of U-0126, U-0124, was used as control. Unpaired t-tests.  
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Data are shown as mean ± SEM. 
 
Figure 5. Presynaptic cap-dependent protein synthesis is essential for iLTD 
(A-C) Paired recordings in which M7 was loaded presynaptically via the patch pipette. 
(A) Top: regular-spiking action potential firing pattern characteristic of DSI sensitive and thus 
CB1-expressing interneurons. Middle: Representative traces collected before, during, and after 
DSI. Bottom: DSI summary data. DSI: -0.8 ± 6.2% compared to baseline; p <0.00001, paired t-
test. uIPSC (unitary IPSC).  
(B) Representative time course plot for an attempted iLTD experiment in which M7 (250 µM) 
was loaded presynaptically into the interneuron for 86 min prior to inducing iLTD. Black bar, 
mDSI protocol. Presynaptic action potentials (averaged) and corresponding evoked uIPSCs are 
shown (example responses and failures in gray; averaged responses and failures in black).  
(C) Summary data. (1) and (2) refer to baseline and after iLTD induction, respectively (see gray 
shaded areas in panel B). Pr during baseline: 0.62 ± 0.11 vs. after iLTD induction: 0.56 ± 0.12; p 
= 0.56546, paired t-test. Efficacy during baseline: 26.4 ± 13.2 pA vs. after iLTD induction: 23.0 ± 
11.9 pA; p = 0.48395, paired t-test. See Figure S2A for time-course plots of summary data. 
(D-F) Paired recordings in which M7 was loaded postsynaptically via the patch pipette.  
(D) Similar to panel A. DSI: 1.1 ± 3.9% compared to baseline; p <0.00001, paired t-test. 
Magnitude of DSI was not significantly different from that in panel A; p = 0.90793, unpaired t-
test. 
(E) Similar to panel B, but M7 (250 µM) was loaded postsynaptically into the CA1 pyramidal cell 
for 40 min prior to inducing iLTD. 
(F) Summary data. Pr during baseline: 0.75 ± 0.08 vs. after iLTD induction: 0.42 ± 0.09; p = 
0.00193, paired t-test. Efficacy during baseline: 28.4 ± 12.3 pA vs. after iLTD induction: 8.9 ± 
5.3 pA; p = 0.04314, paired t-test. The baseline Pr and synaptic efficacy were not different 
between M7 loaded presynaptically and postsynaptically experiments (p = 0.30708 and p = 
0.70520, respectively, unpaired t-tests). See Figure S2B,C for M7 loaded postsynaptically 
positive control.  
Data are shown as mean ± SEM. 
 
 
Figure 6. Somatic protein synthesis is dispensable for iLTD 
(A) Representative iLTD time course plot for a paired recording in acute hippocampal slices in 
which gelonin (3 µM) was loaded presynaptically into the CA1 interneuron for ~100 min prior to 
inducing iLTD. Black bar, mDSI protocol. 
(B) Summary data. Pr during baseline: 0.71 ± 0.10 vs. after iLTD induction: 0.44 ± 0.12; p = 
0.02257, paired t-test. Efficacy during baseline: 24.3 ± 8.7 pA vs. after iLTD induction: 9.0 ± 4.5 
pA; p = 0.01699, paired t-test. The baseline Pr and synaptic efficacy were not statistically 
different between gelonin loaded presynaptically and M7 loaded postsynaptically, which served 
as control (p = 0.64124 and p = 0.98827, respectively, unpaired t-tests) (c.f. Figure 5F). 
(C) Gelonin (3 µM) blocks somatic translation at the single-cell level in acute hippocampal 
slices. Left panel: representative confocal images of two neighboring CA1 interneurons that 
were patched near-simultaneously and loaded via the patch-pipette with the morphological dye, 
lucifer yellow (2 mM). Gelonin (3 µM) was also loaded into the cell on the right for ~30 min. The 
pipettes were gently withdrawn. Slices were then processed for FUNCAT. Middle panel: 
FUNCAT signal from the same slice. Right panel: merged images. 
(D) Summary data and FUNCAT quantification (fluorescence intensity, in arbitrary units, 
normalized to control) for dual recordings. Cells were loaded for 30.0 ± 2.3 min. Control: 1.0 ± 
0.0 vs. gelonin: 0.67 ± 0.09, p=0.0313, Wilcoxon matched-pairs signed rank test. Homogenous 
ROIs (n = 2) were selected from each neuronal somata (n = 6 slices).  
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(E) Whole-cell recordings in which gelonin (3 µM) loaded postsynaptically into CA1 pyramidal 
cells blocked chemically-induced mGluR-LTD (DHPG, 50 µM, 5 min, black bar). Control: 62.2 ± 
8.1% vs. gelonin: 98.2 ± 6.4%; p = 0.00221, unpaired t-test. Gelonin was loaded for 32.0 ± 2.3 
min before DHPG application.  
(F) Field recordings in which the microtubule depolymerizing compounds nocodazole (20 µM) 
and colchicine (100 µM) did not affect chemical iLTD. Control: 77.2 ± 3.1% vs. colchicine: 76.0 ± 
2.5% vs. nocodazole: 79.8 ± 2.0%; F[2,17] = 0.72626; p = 0.49813, one-way ANOVA. Slices 
were pre-incubated in colchicine and nocodazole for >2.5 hrs (usually ~ 4 hrs, up to 5 and 8 hrs, 
respectively) and continuously perfused. See Figure S4 for nocodazole positive control.  
Data are shown as mean ± SEM. 
 
Figure 7. Ribosomes are present in CB1-expressing interneuron axons and terminals  
(A) Fixed mouse hippocampal slices were immunostained against 5.8S rRNA using the 
monoclonal Y10b antibody (green) and CB1 antibody (blue). Deconvolved confocal image of 
5.8S rRNA immunostaining in CA1 cell body layer reveals heavily labeled perinuclear cytoplasm 
of pyramidal cells (asterisks). Note the characteristically dense meshwork of axons and 
preterminal axon segments expressing CB1 receptors (box). Compared with control, sections 
pretreated with nuclease enzymes had significantly less 5.8S rRNA immunolabeling (quantified 
in panel D), confirming the specificity of the antibody and labeling procedure. 
(B) Representative maximum intensity volume view of correlated confocal and 3D-STORM 
microscopy images shows 5.8S rRNA immunolabeling inside a CB1-expressing axon terminal 
(panel A, white box). An area within CB1-expressing axon terminals was selected from the 
central confocal slice using an unbiased active contour algorithm (gold outline in xy plane of 
panels B and C). The number of STORM localization points within these ROIs was used to 
calculate density values for each bouton. 
(C) Similar to panel B, but for ribosomal protein, rpS6. Same imaging modality as in panel B. 
(D) Left panel: pretreatment with nuclease enzymes decreased STORM localization point 
density in CB1-expressing axon terminals (n = 28 ± 2 standard deviations, unpaired t-test). Right 
panel: Interneuron axon terminals (n = 29 ± 1) contained significantly more ribosomal labeling 
compared to preterminal axon segments (n = 13 ± 3) and pyramidal cell nuclei (n = 4), 
representing background staining, one-way ANOVA. Each graph shows raw data normalized to 
control axon terminals (n = 3 mice per condition).  
(E) Similarly, rpS6 immunopositive STORM labeling density was significantly higher in axon 
terminals (n = 21 ± 3) than background staining in nuclei (n = 4), one-way ANOVA. Preterminal 
segments (n = 13 ± 2). 
(F) Nanoscale spatial distribution of 5.8S rRNA and rpS6 immunolabeling was virtually identical 
(c.f. Figure S6A-C). Maximal clustering between pairs of localization points occurred near ~50 
nm (note apparent clustering of points in panels B and C). ε refers to the Euclidian distance 
between point pairs that are confined by the active contour border. The y-axis refers to the 
number of point pairs separated by less than ε normalized to a randomized distribution of such 
point pairs for each distance. Filled symbols represent the mean and error bars the 95% 
confidence interval.  
(G) Dual-channel 3D-STORM imaging of CB1 and 5.8S rRNA immunolabeling shows high 
density of ribosomal material at the inner plasma membrane surface of CB1-expressing axon 
terminals (n = 25 boutons, 2 mice, representative images in panel H). The outer surface of the 
bouton was largely devoid of 5.8S rRNA immunolabeling. The signal was present at low density 
in surrounding neuropil and accumulated in neighboring cells with distance from the terminals. 
Filled symbols are mean ± 95% confidence interval. NLP, number of localization points. 
(H) Dual-channel 3D volume renderings of two adjacent CB1-expressing axon terminals (single 
arrowhead and double arrowhead) demonstrate 5.8S rRNA immunolabeling inside the convex 
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hull fit to CB1 localization points (silver lines). Dotted line indicates neighboring postsynaptic 
neuron cell body (asterisk).  
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Supplemental Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1 (related to Figure 2): Transcription is not required for iLTD.  (A) Transcription inhibitor actinomycin-D 
(25 µM) did not affect chemical iLTD. Control: 79.2 ± 4.6% vs. actinomycin-D: 82.0 ± 3.2; p = 0.60436, unpaired t-test. 
Slices pre-incubated in actinomycin-D for >1 hr. Actinomycin-D is irreversible; it was not present during field 
recordings. Data are shown as mean ± SEM. (B) To confirm actinomycin-D efficacy (act-D, 25 µM, slices pre-incubated 
for 1 hr), BDNF exon III mRNA transcription was measured with RT-PCR on slices stimulated with 60 mM KCl/20 µM 
forskolin (Tao et al., 1998). Compared with vehicle (VEH)-treated slices, act-D reduced BDNF exon III transcription 
(act-D: 0.85-fold decrease vs. vehicle: 1.67-fold increase). We also measured constitutive ARC mRNA transcription. 
Hippocampal ARC mRNA has a half-life of ~1 hr (Rao et al., 2006). Compared with naïve, VEH-treated control, ARC 
mRNA was reduced (0.75 fold) in slices pretreated for 1 hr with act-D. Band intensity quantified using ImageJ. 
 
 
 
 
  
-20 0 20 40 60 80 100
40
60
80
100
120
Time (min)
n = 7
n = 13
actinomycin-Dcontrol
fI
P
S
P
 (
%
)
1 2
A
veh   stim
  VEH    act-D  
BDNF III
ARC
veh   stim
act-D VEH
B
SR 141716
activity
WIN
100 V
20 ms
1
2
1
2
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2 (related to Figure 5): Postsynaptic protein synthesis is dispensable for iLTD. (A) Summary data replotted 
from paired recording in Figure 5 to illustrate time-course of averaged uIPSCs (calculated from synaptic efficacy). M7 
loaded presynaptically (89.1 ± 20.3%) vs. M7 loaded postsynaptically (24.0 ± 6.2%; p = 0.01482, paired t-test). Because 
stochastic transmitter release is more apparent in paired recordings, data were binned every 5 min. Black bar, mDSI 
protocol. (B) iLTD still relied on CB1 signaling when M7 (250 µM) was loaded postsynaptically into CA1 pyramidal 
cells. M7 post: 81.9 ± 3.8% vs. M7 post + AM251 (4 µM, n = 3) or SR 141716 (4 μM, n = 4): 102.5 ± 2.7%; p = 
0.00056, unpaired t-test (AM251 and SR 141716 results pooled because there was no difference). M7 was loaded 
postsynaptically for 29.5 ± 4.1 min prior to inducing iLTD under control conditions and 27.1 ± 1.5 min in the presence of 
CB1 blockers. Slices pre-incubated (> 1hr) and continuously perfused with AM251 or SR 141716. Black bar, mDSI 
protocol. (C) Chemically-induced mGluR-LTD (DHPG, 50 µM, black bar) was blocked by loading M7 (250 µM) 
postsynaptically into CA1 pyramidal cells for 19.9 ± 2.7 min. Control: 83.5 ± 5.4% vs. M7 post: 114.0 ± 7.1%; p = 
0.00581, unpaired t-test. Data are shown as mean ± SEM. 
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Figure S3 (related to Figures 5 and 6): iLTD likely involves axonal protein synthesis. (A) Magnitude of iLTD (i.e. 
synaptic efficacy expressed as % of baseline) re-plotted from paired recordings (c.f. Figure 5B,C,E,F and Figure 6A,B) 
as a function of when iLTD was induced. Consistent with M7 diffusing into remote axonal compartments to exert its 
blocking effect, the blocking effect of M7 (250 μM) positively correlated with loading time (Pearson’s r = 0.64687; p = 
0.04323). The average time iLTD was induced, and therefore the time interneurons were held in the whole-cell recording 
configuration prior to inducing iLTD, was not significantly different between M7 loaded presynaptically (79.3 ± 14.5 
min) vs. M7 loaded postsynaptically (67.5 ± 11.4 min); p = 0.53521, unpaired t-test. Gelonin (3 μM) was loaded 
presynaptically for 105.3 ± 4.9 min to block translation in somata/proximal neurites (c.f. Figure 6C,D). Data are shown 
as mean ± SEM. (B) M7 proxies, but not gelonin, were detected in CA1 interneuron putative axons in acute hippocampal 
slices using two-photon fluorescence microscopy. Top two rows: images were collected after loading M7 proxy Alexa 
Flour 594 (alexa-594, ~760 Da, 250 µM, shown in red) and fluorescently labeled gelonin-Alexa Fluor 488 (gelonin-488, 
~30 kDa, 30 µM, shown in green) for >100 min in paired recordings (iLTD was observed in these paired recordings, data 
not shown). Whereas M7 proxy was readily detected in somata, dendrites, and axons, gelonin was detected only in 
somata and proximal dendrites, not axons. M7 is ~800 Da. Bottom row: interneuron loaded with M7 proxies alexa-594 
(250 µM, shown in red) and Lucifer yellow (~460 Da, 250 µM, shown in green). Both M7 proxies were detected in 
somata, dendrites, and putative axons in <1 hr. This experiment also demonstrates that we can detect green fluorescence 
in axons. Putative axons characterized by their thin width and “beads on a string” appearance.  (C) Summary data for 
panel B. Fluorescence was normalized to the soma for each condition, giving a relative measurement for each 
fluorophore. Background noise was higher in the gelonin group because we increased the sensitivity of the green 
fluorescence detector in an effort to detect gelonin. Dendritic measurements (<50 µm from soma). Putative axon 
measurements (>250 µm from soma). n = ROIs imaged per condition for 7 interneurons loaded with alexa-594 (250 µM), 
2 with lucifer yellow (250 µM), and 5 with gelonin-488 (n = 2 with 30 µM and n = 3 with 3 µM). 
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Figure S4 (related to Figure 6): Impact of nocodazole on intrinsic electrophysiological properties and microtubule 
assemblies.  (A) Passive and active intrinsic membrane properties of CA1 neurons in acute hippocampal slices pre-
exposed to nocodazole (20 μM) for 5 and 8 hrs. Top: nocodazole did not significantly change the membrane input 
resistance (RI). Voltage deflections collected from pyramidal cells in response to -120, -80, -40, and +40 pA square 
pulses delivered through the somatic recording pipette. Dashed vertical line indicates measurement of steady-state 
voltage. Shown below the example sweeps are the averaged steady-state voltage-current relationships for control and 
nocodazole (n = 3 pyramidal cells each). Slope of the best-fit line was used to calculate RI. Shown at right is RI summary 
data for pyramidal cells (circles) and interneurons (squares). Pyramidal cells: control: 116.9 ± 6.87 MΩ vs. nocodazole: 
102.1 ± 7 .64 MΩ; p = 0.22402, unpaired t-test. Interneurons: control: 244.2 ± 28.3 MΩ vs. nocodazole: 206.2 ± 23.7 
MΩ; p = 0.36086, unpaired t-test). As expected, RI was higher for interneurons. Also shown are: firing properties 
(number of spikes in response to +80 pA square pulse). Control: 3.2 ± 0.4 vs. nocodazole: 2.8 ± 0.7; p = 0.70, unpaired t-
test (results pooled across pyramidal cells interneurons because there was no difference. (B) Microtubule stability 
assessed with second harmonic generation (SHG) microscopy. Microtubules can produce intrinsic optical signals (i.e. 
SHG) in response to two-photon laser-induced excitation (Dombeck et al., 2003). Representative images show 
microtubule bundles in hippocampal CA3 mossy fiber axons (white arrows) in acute slices. Compared with control, acute 
nocodazole (25 μM) treatment disrupted microtubule assemblies. Before (time 0) and after (time 60). s.l., stratum 
lucidum. s.p. stratum pyramidal. (C) Summary data of randomly selected ROIs (n = 16 each) from mossy fiber axons in 
s. lucidum. Control: 99.127 ± 2.7% of baseline; p = 0.8209; nocodazole: 79.5 ± 3.3% of baseline; p <0.0001, Wilcoxon 
matched-pairs signed rank test, n = 3 slices each. Data are shown as mean ± SEM. 
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Figure S5 (related to Figure 7): Immunostaining against ribosomal markers in hippocampal CA1. (A) Low-
magnification (20x) confocal images of CB1 and parvalbumin (PV) staining together with 5.8S rRNA or rpS6. As 
expected, pretreatment of sections with nucleases diminished 5.8s rRNA, but not rpS6 labeling. (B) High-magnification 
(100x) correlated confocal and STORM image of CB1 and 5.8S rRNA immunostaining shows ribosomal labeling in CB1-
expressing axon terminals across the somatic (s. pyramidale) and dendritic (s. radiatum) fields. Nuclease treatment 
substantially reduced 5.8S rRNA labeling. Cell bodies indicated with asterisks. (C) Similar to panel B, but for rpS6. 
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Figure S6 (related to Figure 7): Nanoscale distribution of 5.8S rRNA and rpS6 labeling inside CB1-expressing 
interneuron axon terminals. (A) “Direct STORM” images of 5.8S rRNA were obtained with a commercially available 
secondary antibody labeled with AlexaFluor-647 (activated directly with 405 nm light). “Specific STORM” images of 
rpS6 were obtained with an in-house secondary antibody labeled with Cy3/AlexaFluor- 647 (activated specifically with 
561 nm light). Note that clusters of localization points in CB1-expressing axon terminals contain a mixture of points from 
both channels (see panel E), strongly suggesting the STORM signal originates from the same ribosomal material. As 
expected, due to the inferior sensitivity of the specific channel, the number of localization points from the specific 
channel is lower than the direct channel. (B) Scatterplot of the x and y coordinates of localization points after aligning all 
clusters on their center of mass. Localization points from both channels are distributed around the origin. (C) Cumulative 
probability distributions of the number of specific localization points (rpS6 labeling) for clusters containing 5.8S rRNA 
(n = 484 clusters, 103 boutons, 2 animals) and negative controls where the primary antibody against rpS6 was omitted (n 
= 533 clusters, 105 boutons, 2 animals). A higher number of specific localization points was observed in the presence of 
the rpS6 antibody, indicating that 5.8S rRNA and rpS6 are co-clustered in CB1-expressing axon terminals. (D) Correlated 
confocal and STORM images of a CB1-positive axon terminal co-expressing the presynaptic active zone protein bassoon 
and 5.8S rRNA. Multiple bassoon puncta and multiple ribosomal clusters are present in the bouton. (E) Similar to panel 
A, but for rpS6. (F) Histograms showing the distribution of ribosomal material in axon terminals defined by CB1 (n = 
101 and 125 terminals for 5.8s rRNA and rpS6, respectively, from 3 animals each). STORM localization points 100- 150 
nm from the inside of the CB1 label is greater than expected from a random distribution, consistent with the CB1-5.8S 
rRNA dual STORM data (c.f. Figure 7G). (G) In the same terminals, the distribution of localization points near bassoon 
puncta does not significantly differ from a random distribution, suggesting ribosomes are not orderly arranged around the 
active zone. 
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Figure S7 (related to Figure 7): Ribosomal material in parvalbumin (PV)-expressing axon terminals and 
comparison with CB1-expressing axon terminals. (A) Correlated confocal and STORM microscopy reveals 5.8S 
rRNA immunolabeling in PV-expressing axon terminals of basket cells. In contrast to CB1 labelling, which delimits the 
terminal, PV is expressed within the terminal. (B) Similar to panel A, but for rpS6. (C) Compartmental distribution of the 
total ribosomal signal in CB1 and PV terminals. The distribution of both ribosomal markers within compartments is 
similar. Summary data shows mean ± 2x SEM from 28 and 30 images of 5.8S rRNA and rpS6 staining, respectively, 
from 3 animals, two-sample Kolmogorov-Smirnov test. Analysis performed on images collected at the border between s. 
pyramidale and radiatum. (D) Comparison of ribosomal labeling density between CB1- and PV-expressing axon 
terminals showing medians (filled diamonds) and individual data points (open diamonds) from 3 animals per group (n = 
279 axon terminals were analyzed), unpaired t-test. NLP, number of localization points.  
  
A B 
C D 
8 
 
Supplemental Experimental Procedures 
 
Acute hippocampal slices  
 
Experimental procedures adhered to NIH and Albert Einstein College of Medicine Institutional Animal Care and Use 
Committee guidelines. Acute transverse slices were prepared from young adult male and female Sprague Dawley rats 
and C57BL/6 mice (P15-30). The cutting solution contained (in mM): 215 sucrose, 20 glucose, 26 NaHCO3, 4 MgCl2, 4 
MgSO4, 1.6 NaH2PO4, 2.5 KCl, and 1 CaCl2. The artificial cerebral spinal fluid (ACSF) recording solution contained (in 
mM): 124 NaCl, 26 NaHCO3, 10 glucose, 2.5 KCl, 1 NaH2PO4, 2.5 CaCl2, and 1.3 MgSO4. After ice-cold cutting, slices 
recovered at 34°C (in 50% cutting solution, 50% ACSF) for <30 min and then at room temperature (RT) for >1 hr in 
ACSF. All solutions were bubbled with 95% O2 and 5% CO2 for at least 30 min. Although the form of long-term 
inhibitory synaptic plasticity studied here (i.e. iLTD) is present under physiological recording conditions at 37 °C 
(Younts et al., 2013), inhibitory synaptic transmission is less stable at this temperature, making long-term measurements 
of inhibition (up to 5 hrs in the present study) not practical. We therefore conducted our experiments at 25.5 ± 0.1°C.   
 
Electrophysiology 
 
For whole-cell recordings, CA1 pyramidal cells were blind patched (>100 µm below slice surface) using an upright 
Nikon Eclipse E600FN infrared differential interference contrast microscope (4x and 40x plan fluor objectives, NA = 
0.13 and 0.8, respectively) equipped with a Cohu monochrome CCD camera and voltage-clamped at -60 mV with an 
intracellular recording solution containing (in mM): 135 KMeSO4, 5 KCl, 1 CaCl2, 5 EGTA, 5 NaOH, 10 HEPES, and 10 
glucose; pH 7.2 (280-290 mOsm). IPSCs or EPSCs were pharmacologically isolated with 5 µM NBQX/25 µM D-APV 
or 100 µM picrotoxin to block AMPA/kainate/NMDA or GABAA receptors, respectively. Dendritically originating 
IPSCs/EPSCs and somatically originating IPSCs were evoked with ACSF-filled extracellular stimulating patch-type 
pipettes (~10 µm broken tip) placed in stratum (s.) radiatum or s. pyramidale (<10 µA, 200 µs), respectively (~150-200 
µm from the recording pipette). For extracellular field IPSP (fIPSP) recordings, the stimulating pipette (filled with 
ACSF) and recording pipette (filled with 1 M NaCl) were placed in s. pyramidale (>100 µm below slice surface, ~150-
200 µm apart). 
 
Long-term cell-paired recordings 
 
For paired recordings, interneurons with their soma in s. radiatum (typically >100 µm below slice surface and <200 µm 
from s. pyramidale) were visually identified, patched, and their firing pattern characterized in response to 500 ms, 80-240 
pA somatic square-wave current pulses as described (Younts et al., 2013). Regular-spiking interneurons often show DSI-
sensitivity and therefore express CB1 (Glickfeld and Scanziani, 2006; Pawelzik et al., 2002). CA1 pyramidal cells 
residing in s. pyramidale (at approximately the same depth in slice) were blind-patched with an intracellular recording 
solution containing (in mM): 54.5 CsMeSO4, 60 KCl, 1 CaCl2, 5 EGTA, 2 NaOH, 10 HEPES, and 10 glucose (measured 
Cl
-
reversal, ~ -20 mV). Interneuron action potentials were evoked in current-clamp mode by a 2 ms, 3-5 nA depolarizing 
square wave pulse. Action potential-evoked unitary IPSCs (uIPSCs) were recorded from CA1 pyramidal cells in the 
voltage-clamp mode. Connection probability was ~10%. Only regular-spiking, DSI-sensitive (>50% suppression from 
baseline) connections were analyzed for iLTD experiments. DSI was induced by a 5 s voltage step (-60 to 0 mV) in the 
pyramidal cell and quantified by averaging 4-7 sweeps before, after, and recovery from DSI. During the iLTD portion of 
the experiment, pairs of action potentials (100 ms inter-stimulus interval) were used to evoke uIPSCs (except for two 
interleaved recordings using a 5 ms inter-stimulus interval).  
 
For all paired recordings, action-potential-evoked uIPSCs (i.e. synaptic responses) were clearly resolvable from non-
responses (i.e. synaptic failures). Postsynaptic uIPSCs were classified as responses only if: (a) their latency (2.67 ± 0.13 
ms for all connections, range 1.5 – 4.1 ms, n = 18) was precisely time-locked to the presynaptic action potential; and (b) 
their peak amplitude was >2.3 pA (i.e. the smallest resolvable synaptic responses, which were at least 5 standard 
deviations greater than the root mean square noise across recordings calculated during the baseline; mean ± standard 
deviation root mean square noise: 0.71 ± 0.1 pA, range 0.55 – 0.91 pA, n = 18). Average baseline uIPSC peak amplitudes 
across all paired recordings was 33.4 ± 6.0 pA (range 9.0 – 90.5 pA, n = 18). For quantification, the smallest resolvable 
uIPSC for each connection was identified and used to classify sweeps as responses or failures. We calculated the 
following quantal parameters during the baseline and after inducing iLTD (the same number of sweeps, typically 120, 
were analyzed for each): release probability (estimated as inverse failure rate); synaptic efficacy (average of all action 
potential-evoked postsynaptic responses and failures); and synaptic potency (average of just synaptic responses). Root 
mean square noise was not subtracted from quantal parameters. Importantly, the action potential-evoked uISPC latencies 
across all experimental conditions (calculated from synaptic efficacy during the baseline) were not significantly different 
(M7 loaded presynaptically: 2.91 ± 0.24 ms vs. gelonin loaded presynaptically: 2.43 ± 0.23 ms vs. M7 loaded 
postsynaptically: 2.67 ± 0.19 ms. F[2,15] = 1.18032; p = 0.33415, one-way ANOVA). There also was no difference 
between the average baseline release probability, synaptic efficacy, and synaptic potency across each condition (cf. 
Figure 5C,F and Figure 6B). These analyses indicate that the sampled synaptic connections were not biased towards 
somatic or dendritic inhibitory inputs. To improve the likelihood of maintaining stable, long-term recordings (average 
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paired recording duration: 140.7 ± 13.5 min, range: 90-300 min, n = 18), pyramidal cells were voltage-clamped (after 
testing for DSI at -60 mV) at positive potentials (0-30 mV), which facilitated series/access resistance (RS) stability.  
 
For synaptically-induced iLTD, an at least 20 min baseline was acquired and then the pyramidal cell was returned to -60 
mV. The iLTD induction protocol (see below) was administered at -60 mV. During the induction, interneurons were 
slightly depolarized (via somatic current injection) to yield action potentials at 1-3 Hz because we previously 
demonstrated that iLTD requires both spontaneous presynaptic activity and CB1 activation (Heifets et al., 2008). After 
the induction, the pyramidal cell was returned to the pre-induction holding potential (i.e. 0-30 mV). iLTD was typically 
quantified 30-50 min post induction, but for two recordings it was 15-35 min because one of the two cells became 
compromised (we considered this time valid because iLTD manifests immediately after the induction). To measure cell 
health and stability, interneuron resting membrane potential (Vrest) and input resistance (RI), as well as pyramidal cell RS 
and RI were monitored (with 5 mV hyperpolarizing square wave pulses). If either of the cells became compromised 
before eliciting iLTD, the experiment was rejected; if either became compromised after eliciting iLTD, the analysis was 
curtailed at that time (see above). For M7 loaded presynaptically experiments (n = 6): Vrest for interneurons was -62.9 ± 
1.9 mV during baseline and -62.2 ± 2.3 mV after iLTD induction, and RI for interneurons was 275.4 ± 42.0 MΩ during 
baseline and 187.7 ± 19.5 MΩ after iLTD induction; RS for pyramidal cells was 11.5 ± 0.9 MΩ during baseline and 11.9 
± 1.2 MΩ after iLTD induction, and RI for pyramidal cells was 116.7 ± 14.9 MΩ during baseline and 149.2 ± 22.1 MΩ 
after iLTD induction. For gelonin loaded presynaptically experiments (n = 6, but two interneurons were excluded from 
this analysis, see below): Vrest for interneurons was -60.7 ± 1.4 mV during baseline and -62.3 ± 0.7 mV after iLTD 
induction, and RI for interneurons was 208.8 ± 12.7 MΩ during baseline and 181.5 ± 21.2 MΩ after iLTD induction; RS 
for pyramidal cells was 14.3 ± 1.9 MΩ during baseline and 13.8 ± 1.7 MΩ after iLTD induction, and R I for pyramidal 
cells was 130.9 ± 10.4 MΩ during baseline and 119.2 ± 9.1 MΩ after iLTD induction. For M7 loaded postsynaptically 
experiments (n = 6): Vrest for interneurons was -62.1 ± 1.8 mV during baseline and -61.9 ± 1.8 mV after iLTD induction, 
and RI for interneurons was 231.5 ± 51.5 MΩ during baseline and 211.2 ± 50.2 MΩ after iLTD induction; RS for 
pyramidal cells was 11.9 ± 1.5 MΩ during baseline and 12.6 ± 1.3 MΩ after iLTD induction, and R I for pyramidal cells 
was 116.2 ± 19.7 MΩ during baseline and 133.2 ± 28.4 MΩ after iLTD induction (p >0.10 for each, paired t-tests). 
Notably, there were no differences between conditions in baseline Vrest or RI for interneurons and RS or RI for pyramidal 
cells. These analyses indicate our recordings were stable, and that protein synthesis inhibitors do not significantly alter 
intrinsic membrane properties.  
 
For experiments employing gelonin, the recording pipette tips were first front-filled with K
+
-based intracellular recording 
solution lacking gelonin and then back-filled with the same K
+
-based recording solution containing 3.1 μM gelonin. The 
estimated final concentration of gelonin was 3 μM. For two paired recordings in which gelonin was loaded 
presynaptically for >60 min in the whole-cell configuration, the cell-attached configuration was used to elicit action 
potentials during the iLTD portion of the experiment.  
 
Long-term plasticity induction protocols 
 
Synaptically-induced iLTD (Chevaleyre and Castillo, 2003) was triggered with a theta-burst stimulation (TBS) protocol 
delivered via an extracellular patch-type pipette placed in s. radiatum (Figure 1A). TBS consisted of 5 stimuli (i.e. a 
burst at 100 Hz) delivered 10 times at 5 Hz. This was repeated five times, once every 5 s. We previously demonstrated 
that postsynaptic activity that mimics CA1 pyramidal cell firing in vivo also elicits iLTD (Younts et al., 2013). For the 
present study, postsynaptically-induced iLTD was triggered by multiple episodes of DSI (mDSI). This protocol engages 
iLTD at somatic and dendritic inhibitory inputs. For data presented in Figure 1B and Figure S2B, the iLTD induction 
protocol consisted of 5 s voltage steps from -60 to 0 mV every 15 s for 10 min; for paired-recordings presented in Figure 
5B,C,E,F and Figure 6A,B, the iLTD induction protocol consisted of 2 s voltage steps from -60 to 0 mV every 5 s for 5 
min. To elicit chemical-iLTD (Heifets et al., 2008) in Figure 2A,B,D, Figure 4D,E and Figure 6F, the CB1 agonist WIN 
55,212-2 (WIN; 5 µM) was bath applied for 25 min, and 5 stimuli at 10 Hz were delivered at 0.1 Hz during the last 10 
min of WIN. WIN was chased with the CB1 inverse agonist/antagonist SR 141716 (5 µM) or AM251 (5 µM) to halt CB1 
signaling. To elicit chemical mGluR-LTD in Figure 6E and Figure S2C, 50 uM DHPG was bath applied for 5 min.  
 
Electrophysiology data acquisition and statistics 
 
Baseline and post-induction synaptic responses were monitored at 0.05 Hz during iLTD and 0.2 Hz during DSI. 
Stimulation and acquisition were controlled with IgorPro 5 (Wavemetrics). Shaded boxes in figures correspond to when 
plasticity was analyzed with respect to baseline and when representative traces were collected and averaged. Summary 
data (i.e. time-course plots and bar graphs) are presented as mean ± standard error of mean (SEM). Whole-cell and field 
recording summary data were respectively binned every 1 and 3 min, unless otherwise indicated. Analysis and statistics 
were carried out in OriginPro 7.0 and 9.1 (OriginLab). Significance (p <0.05) was assessed with one-way ANOVA 
(means comparison with post hoc Bonferroni test for electrophysiology and FUNCAT or Tukey test for STORM), 
Student’s paired and unpaired t-tests, Wilcoxon matched-pairs signed rank test, Mann Whitney U test, or Pearson’s 
correlation coefficient, as indicated. All experiments were performed in an interleaved fashion. Unless stated otherwise, 
“n” represents number of independent cells or field recordings in slices. 
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Electrophysiology reagents 
 
Stock reagents were prepared according to the manufacturer’s recommendation in water, DMSO (<0.01% final volume 
during experiments), or phosphate buffered saline (PBS), stored at -20°C, and diluted into ACSF or intracellular 
recording solutions as needed. NBQX, D-APV, SR 141716, and WIN were acquired from the NIMH Chemical Synthesis 
and Drug Supply Program; m
7
GpppG (M7) from New England BioLabs; gelonin from Enzo Life Sciences; 4EGI-1 from 
EMD Chemicals; cycloheximide, anisomycin, picrotoxin, ISRIB, actinomycin-D, and salts for making cutting, ACSF, 
and intracellular recording solutions from Sigma-Aldrich; DHPG, AM251, nocodazole, rapamycin, U-0126, U-0124, and 
SB 202190 from Tocris; colchicine and torin-2 from Cayman Chemical; Lucifer yellow CH (lithium salt), Alexa Fluor-
594, and Alexa Fluor-488 protein labeling kit from ThermoFisher Scientific. Reagents were either acutely bath applied, 
diluted into the intracellular recording solution, or preincubated with slices, as indicated in Results.  
 
Fluorescent noncanonical amino acid tagging (FUNCAT) in hippocampal cultures and slices 
 
Primary hippocampal neurons were prepared from E18-19 rat brains and grown (12-18 days) on poly-D-lysine coated 
coverslips in Neurobasal media with Glutamax and B-27 supplement (Invitrogen). Neurons were seeded at a density of 
65,000 cells/well in a 12-well plate. Neuron cultures grown for 18 days in vitro were washed once with PBS (0.01 M, pH 
= 7.4) and pre-incubated with methionine-free DMEM (Invitrogen) for 30 min to deplete methionine stores. They were 
then incubated for 1.5 hrs with 100 μM azidohomoalanine (AHA) (Iris Biotechnology, Germany) and treated with 
reagents, as described in Results, in methionine-free DMEM at 37°C. Neurons were then fixed in 4% paraformaldehyde 
(PFA), permeabilized with Triton-X 100 and incubated with Click-it® reaction buffer containing 2 μM Alexa Fluor-488 
alkyne (Invitrogen) for 30 min at RT. Following the click reaction, samples were blocked for 1 hr at RT in blocking 
solution (4% (wt/vol) bovine serum albumin, BSA, in PBS), and immunocytochemistry was performed according to 
standard procedures using chicken anti-microtubule associated protein (MAP2) at 1:500 (EnCor Biotechnology Inc., 
7225-4) to specifically label neuronal dendrites.  
 
Images were obtained on a Zeiss Axio-Observer inverted microscope (20x and 63x plan apochromat objectives, NA = 
0.8 and 1.4, respectively) equipped with an AxioCam Mrm (12-bit resolution) camera using the same settings for all 
samples within an experiment. Experimenter was blind to the treatment condition during imaging and analysis. Image 
analysis was performed with ImageJ (NIH). For Figure 4A, images were acquired at 20x and MAP2 staining, which 
exclusively labels microtubules in neurons, was used to randomly select neurons for image analysis. Thus, translation 
was assayed only in neurons, not astrocytes or other cells. Thresholded MAP2 signal was used to generate a region of 
interest (ROI) for an image. In this case, the ROIs included somata and dendrites of all (i.e. 2-8) neurons in a single 
image (~5 images/condition). The mean FUNCAT fluorescence intensity was calculated to give a single value/image. For 
Figure 4C, images of neurons were acquired at 63x to resolve CB1 immunostaining. To assess FUNCAT signal 
underneath CB1 puncta and putative axons, a thresholded MAP2 mask was applied to the CB1 channel. CB1 labeling that 
fell within the MAP2 mask was cleared. The remaining CB1 labeling was thresholded to generate a second mask that was 
applied to the FUNCAT channel. Values reported are the mean fluorescence (i.e. pixel intensity, or gray value) of all 
regions of interest (ROI) in the image normalized to the mean fluorescence of all ROIs in the control group. For image 
presentation, the background was subtracted and the image cropped.  
 
We carried out FUNCAT on acute hippocampal slices using a previously published protocol (Tom Dieck et al., 2012). 
For experiments in Figure 1E,F, slices were incubated in AHA (1 mM) in the presence of cycloheximide, anisomycin, or 
DMSO (control) in oxygenated ACSF. After 2.5 hrs, slices were fixed overnight in 4% PFA and 5% sucrose PBS. The 
following day, slices were embedded in agar and resectioned to 35 µm. Slices were permeabilized and blocked for >2 hrs 
at RT. Click-it® reaction was performed using 1 µM Alexa Fluor-647 (ThermoFisher Scientifc) for 48 hrs at RT. Slices 
were washed and mounted before imaging on a Zeiss LSM 510 Meta Duo V2 confocal microscope (63x plan apochromat 
objective, NA = 1.4) using the same settings for all samples within an experiment. Experimenter was blind to the 
treatment condition during imaging and analysis. Single plane images (63x) were randomly collected (from the middle of 
each slice, ~17 µm deep). ImageJ was used to quantify fluorescence, as described above, by generating a circular ROI 
within neuronal somata located in the CA1 cell body layer.  
 
For the slice FUNCAT experiments presented in Figure 5C,D, two regular-spiking CA1 interneurons located in s. 
radiatum were near-simultaneously patched using the K-based intracellular recording solution described above, 
supplemented with the morphological dye, Lucifer yellow (2 mM). One of the recording solutions also contained gelonin 
(3 µM) to block somatic protein synthesis. To enable post-hoc identification of the interneurons with confocal 
microscopy, contrast images of pipette position relative to slice orientation were collected. After the ~30 min loading 
period, during which cell health (e.g. holding current and membrane input resistance) were monitored 
electrophysiologically, the pipettes were carefully withdrawn such that the cell membrane could reform (which was 
confirmed in the confocal images, see below). Slices were then placed in carbogenated (95% O2/5% CO2) ACSF 
supplemented with 1 mM AHA for 2-3 hrs. After overnight fixation in 4% PFA and 5% sucrose PBS, slices were 
blocked and permeabilized in B-Block (10% donkey serum, 5% sucrose, 2% BSA, 0.1% Triton X) for 1 hr. Click-it® 
reaction was performed overnight with 1 µM Alexa Fluor-647 alkyne. Slices were imaged using confocal microscopy as 
described above. A z-stack spanning the entire soma of both cells was acquired. For analysis, two ROIs were selected 
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from the somatic cytoplasm (non-nucleus) and averaged to give a single value for each cell. Slices that did not contain 
both somata were excluded. Gelonin containing cells were identified by registering the confocal and contrast images. 
 
Reverse transcription-polymerase chain reaction (RT-PCR) 
 
Following the manufacturer’s (Fermentas) instructions, isolated RNA was treated with DNase for 30 min at 37°C and 
then heat inactivated for 10 min at 65°C. cDNA reactions were prepared using Maxima RT with random hexamers (100 
pM). Taq polymerase was used for subsequent PCRs with gene-specific primers for Arc (forward: GCT CGG TGA AGA 
ACT GGG TGG A; reverse: GGC TGG GTC CTG TCA CTG GCT A) and BDNF exon III (forward: CCC AGT CTC 
TGC CTA GAT CAA ATG G; reverse: ACT CGC ACG CCT TCA GTG AGA A). Band intensity quantified in ImageJ. 
 
Gelonin/Alexafluor-488 protein labeling 
 
Gelonin (~30 kDa) was incubated with reactive Alexa Fluor-488 (ThermoFisher Scientific) for 45 min, according to the 
manufacturer’s instructions. Gelonin-488 containing solution was purified using a P6 Bio-Gel size exclusion 
chromatography resin column (BioRad). All eluted fractions (~1 mL each) were retained, and using a UV illuminator, 
fluorescence was identified in fractions 2, 6, 7, 8, and 9. To identify protein, 1 μL from each fraction was dotted on a 
nitrocellulose membrane and stained with Ponceau S (Sigma). Only fraction 2 was positive for protein. Gelonin-488 
concentration was estimated from the known gelonin concentration added to the column and the total volume of each 
elution fraction. Just prior to experimentation, gelonin-488 was diluted into K
+
-based intracellular recording solution. 
The recording pipette tips were first front-filled with recording solution lacking gelonin-488 and then back-filled with 
solution containing gelonin-488. Estimated final concentration of gelonin-488 was ~3-30 μM. The morphological dye 
and M7 proxy Alexa Fluor-594 also was included in the recording solution. Interneurons in s. radiatum were whole-cell 
patch clamped and subsequently imaged using two-photon fluorescence microscopy (see below).  
 
Two-photon microscopy 
 
To track the diffusion of morphological dyes and M7 proxies (i.e. Alexa Fluor-594 and Lucifer yellow) and gelonin-488 
in interneuron somata, dendrites, and putative axons, we carried out live imaging of loaded neurons in acute 400 μm 
thick slices using an Ultima In Vitro (Bruker Corporation) two-photon laser scanning fluorescence microscope (60x fluor 
objective, NA = 1.00, Nikon) equipped with an Insight Ti:Sapphire laser (Spectra Physics) tuned to 820 nm and a 
galvanometer-based scanhead. Laser power at the back aperture was between 5.6 and 31.7 mW. High intensity laser 
power was needed to detect signal in putative axons. To optimize dual color epifluorescence detection of Alexa Fluor-
594 and Alexa Fluor-488, a 575 nm dcxr dichroic mirror and 607/45 nm and 525/70 nm barrier filters were placed in 
front of the ‘red’ photomultiplier tube (PMT, multi-alkali, Hamamatsu) and ‘green’ PMT (GaAsP, Hamamatsu), 
respectively. Images were created on the NI 6110 board acquired with Prairie View 5.3U2 Beta software. During 
imaging, slices were constantly perfused with carbogenated ACSF at 25.0 ± 0.1°C. Z-stacks were collected shortly after 
achieving the whole-cell recording configuration and at various times (up to 1.5 hr) after loading Alexa Fluor-594 (250 
μM), Lucifer yellow (250 μM), or gelonin-488 (3-30 μM). We loaded these concentrations to match the M7 and gelonin 
paired-recordings. Because gelonin-488 was expected to produce less fluorescence (detected with the green PMT) than 
Alexa Fluor-594, in an effort to detect gelonin-488 we set the green PMT gain higher than the red PMT gain. ImageJ was 
used for analysis. z-stacks were max projected. An ROI was selected from the corner of each channel (same location 
between channels), where there was no signal (i.e. background noise), and the mean gray value was computed. This 
value was respectively subtracted from each channel (i.e. red, green). Three circular ROIs were then selected from the 
soma, proximal dendrite, putative axon, and corners. The mean gray value was calculated for each. Values plotted are 
normalized to the soma for each fluorophore. For image presentation, z-stacks were max-intensity projected and 
background subtracted. 
 
To assess microtubule integrity, we live imaged microtubule assemblies in 400 μm thick acute hippocampal slices using 
second harmonic generation microscopy (Barnes et al., 2010; Dombeck et al., 2003) on an inverted Olympus IX81 
Fluoview FV1000 multiphoton microscope (25x XL plan N objective, NA = 1.05) equipped with a Mai Tai-Deep See 
Ti:Sapphire laser (Spectra Physics) tuned to 840 nm. The forward propagating second harmonic generation was collected 
in the transmitted direction, bandpass filtered at 425/30 nm (Semrock), and detected using a PMT (Hamamatsu). Images 
were acquired with Fluoview software. During imaging, slices were constantly perfused with carbogenated ACSF and 
maintained at 27.0 ± 0.1°C. Z-stacks were collected from mossy fibers in s. lucidum. Nocodazole was bath applied 
immediately after collecting the first z-stack (time 0). Images were collected at time 0 and 60 min later. Microscope 
settings remained constant during image acquisition. ImageJ was used for analysis. Circular ROIs were randomly 
selected from s. lucidum and analyzed at time 0 and 60 min. Data were normalized to the mean gray value for each group 
at time 0. For image presentation, z-stacks were max-intensity projected and background subtracted.  
 
Stochastic optical reconstruction microscopy (STORM) 
 
Experimental procedures were approved by the Hungarian Committee of the Scientific Ethics of Animal Research 
(License: XIV-1-001/2332-4/2012) and performed according to the Hungarian Act of Animal Care and Experimentation 
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(1998, XXVIII, Section 243/1998), which adhere to the European Council Directive of 1986 (86⁄609⁄EEC; Section 
243/1998). Male Sprague-Dawley rats (P25, n = 2) and C57BL/6N mice (P27-41, n = 11) were deeply anesthetized, and 
acute hippocampal slices (300 µm thick) prepared as described (Lee et al., 2015). Slices recovered in solution containing 
(in mM): 75 sucrose, 85 NaCl, 2.5 KCl, 25 glucose, 1.25 NaH2PO4, 4 MgCl2, 0.5 CaCl2, and 24 NaHCO3 for 1 hr at 34°C 
and were then transferred to a chamber containing ACSF (in mM): 126 NaCl, 2.5 KCl, 26 NaHCO3, 2 CaCl2, 2 MgCl2, 
1.25 NaH2PO4, and 10 glucose, bubbled with 95% O2 and 5% CO2 for 60 mins at RT. The sections were transferred into 
PB (0.01 M phosphate buffer, pH = 7.4) containing 4% (wt/vol) PFA and fixed for 40 hrs at 4°C. 
 
Tissue processing, immunostaining, and imaging were performed following our recently published protocol (Barna et al., 
2016). Hippocampal slices were re-sectioned to 20 µm free-floating sections, washed extensively in PB and Tris-buffered 
saline (TBS, 0.05 M Tris and 0.9% (wt/vol) NaCl, pH = 7.4), and blocked in TBS containing 1% (wt/vol) BSA and 0.3% 
(vol/vol) Triton X-100. Sections were then incubated in TBS containing a combination of 2 or 3 (where indicated) of the 
following primary antibodies for 20 hrs at RT: affinity-purified guinea pig anti-CB1 at 1:2000 (Fukudome et al., 2004); 
mouse monoclonal anti-5.8S rRNA, clone Y10b at 1:500 (Santa Cruz, sc-33678) (Lerner et al., 1981); rabbit monoclonal 
anti-rpS6, clone 5G10 at 1:200 (Cell Signaling, 2217); affinity-purified goat anti-parvalbumin at 1:5000 (Swant, PVG-
214); mouse monoclonal anti-bassoon, clone SAP7F407 at 1:2000 (Abcam, ab82958); affinity-purified rabbit anti-
bassoon at 1:1000 (Millipore, ABN255). After washing in TBS, sections were incubated in TBS containing a 
combination of 2 or 3 secondary antibodies (2 µg/mL) for 4 hours at RT: CF568 anti-guinea pig IgG (Biotium, 20377); 
CF568 anti-mouse (Biotium, 20105); Alexa Fluor-647 anti-mouse IgG (Jackson, 715-605-150); Alexa Fluor-647 anti-
rabbit (Jackson, 711-605-152), Alexa Fluor-488 anti-goat (Jackson, 705-545-147); Alexa Fluor-488 anti-guinea pig 
(Jackson, 706-545-148); Cy3-Alexa Fluor-647 anti rabbit (prepared in-house). Sections were then washed in TBS and PB 
and mounted on glass coverslips. 
 
To validate 5.8S rRNA-immunostaining specificity, we treated slices with nucleases. After fixation, sections were 
extensively washed in PB and incubated in TBS containing 0.3% (vol/vol) Triton-X100 for 30 mins. Sections were then 
washed 3x (10 mins each) in enzyme buffer (50 mM Tris and 5 mM CaCl2, pH = 8) and incubated for 60 mins at 37°C in 
enzyme buffer containing 300 U/mL micrococcal nuclease (New England Biolabs, M0247) and 30 µg/mL RNAse A 
(Fermentas, EN0531). For control experiments, nucleases were omitted from the buffer. After incubations, sections were 
extensively washed in PB and TBS and blocked for 45 mins in TBS containing 1% (wt/vol) BSA. Primary antibodies 
were added, and the immunostaining was completed as described above. For low-magnification images, samples were 
covered in Vectashield, and confocal images were recorded using a 20x plan apo VC objective (0.75 NA) on a Nikon 
AIR confocal microscope.  
 
Correlated STORM and confocal imaging was carried out as described (Barna et al., 2016; Dudok et al., 2015). Samples 
were covered in imaging medium consisting of Dulbecco’s PBS containing 5% (wt/vol) glucose, 0.1 M 2-
Mercaptoethylamine (Sigma, 30070), 1 mg/mL glucose oxidase (Sigma, G2133), and 1500 U/mL catalase (Sigma, C30). 
Confocal z-stacks were collected using 488, 561, or 647 nm laser excitation and a Nikon CFI apochromat TIRF 100x oil 
immersion objective (1.49 NA) on a Nikon N-STORM setup equipped with a C2 confocal scan head. The same field of 
view was then imaged in astigmatic 3D directSTORM mode with continuous illumination through the TIRF unit 
(equipped with a 4x lens to focus the laser) with 405 nm and 647 nm laser excitation for 10,000 frames at 31 Hz for 
single-channel STORM. For dual-channel directSTORM (i.e. CB1 and 5.8S rRNA), CF568 was selected for the second 
channel (Lehmann et al., 2016). Continuous illumination with either 405 nm and 561 nm or 405 nm and 647 nm laser 
was alternated every 2,500 frames for a total imaging length of 20,000 frames. For dual-channel STORM with sequential 
activation (i.e. 5.8S rRNA and rpS6), 8-frame cycles (activation with 405 nm and 561 nm, 3-3 frames of imaging with 
647 nm after each activation frame) were repeated 1,500 times. After data acquisition, the confocal images were 
deconvolved with Huygens software (SVI). Identification of single-molecule localization points was performed with 
NIS-Elements N-STORM module (Nikon). Localization point precision was measured from the standard deviation of 
coordinates in isolated clusters (Dudok et al., 2015) at 13 nm and 34 nm in the lateral and axial dimensions, respectively. 
The numerically calculated localization accuracy for determining the position of one blinking event was 6.8 nm with 
single channel STORM and 10.6 nm with dual-channel STORM. 
 
STORM and confocal image pairs were analyzed in VividSTORM. Axon terminal ROIs were selected using unbiased 
automated active contour selection. Preterminal axon segments were freehand selected. Nuclear ROIs (not including 
nucleoli) were selected with circles. Nanoscale spatial distribution of the STORM signal (i.e. localization points) was 
determined using custom-written scripts (Python). Clustering between localization points was assessed by determining 
the number of point pairs located within a series of 3D Euclidean search distances of a given ROI. This value was 
normalized to the mean of 100 randomized control measurements for each individual ROI. To quantify the distance of 
5.8S rRNA localization points from the presynaptic plasma membrane, a 3D convex hull was fit to CB1 localization 
points, clearly outlining the axon terminal. Somata and proximal dendrites were manually selected based on the 5.8S 
rRNA confocal image, and localization points within or outside these regions were categorized as cytosolic or neuropil, 
respectively. The distance (in 25 nm bins) of each 5.8S rRNA localization point inside and outside the terminal from the 
surface of the convex hull was calculated. Numbers of 3D localization points per bin were normalized to the area of the 
bin. 
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To estimate the relative quantity of ribosomal labeling in presynaptic compartments, images of CB1 and PV confocal and 
5.8S rRNA or rpS6 STORM immunostainings were segmented into 4 categories. Cell bodies and thick apical dendrites 
were selected manually based on the confocal image of ribosomal staining. CB1 and PV channels were thresholded using 
Otsu’s method, and positive pixels were used as the area for CB1- and PV-positive processes, respectively. The 
uncategorized areas of the images contained ~25% of total STORM labeling. For the measurement of the distribution of 
ribosomal STORM signal in relation to the outline of the bouton and preterminal axon segment, a 2D spline was fit on 
the points of the ROI selection, and the 2D distance of each localization point from the spline was determined. For the 
distance from bassoon, the bassoon channel in the deconvolved confocal z-stack was thresholded, and the 3D position of 
positive voxels was recorded. The 3D distance of each localization point from the nearest bassoon-positive voxel inside 
the axon terminal was determined. To estimate the expected distributions, points (100 times the number of localization 
points) were placed in random 3D positions in each axon terminal, and the distances were measured as described above. 
Finally, the number of points per distance bin was normalized to the number of axon terminals (times 100 for randomized 
points). The 3D bouton views were generated using custom scripts. Perspective 3D STORM renderings of localization 
points were constructed using Visual Molecular Dynamics software. All images within each experiment were processed 
in parallel using identical imaging and analysis conditions.  
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